Results 161 to 170 of about 21,646 (232)

Letter to the editor regarding "Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study" by Purrucker et al. [PDF]

Neurol Res Pract
Zupan M, Šabovič M, Frol S.
europepmc   +1 more source

Tutorial on non inferiority trial in pharmaceutical research: an important and applied issue. [PDF]

Saudi Pharm J
Madadizadeh F, Afzal G.
europepmc   +1 more source

Management of Recurrent Venous Thromboembolism on Anticoagulation. [PDF]

J Clin Med
Eatrides J, Singh A, Patel A, Jaglal M, Rajasekaran Rathnakumar G, Abdallah E, Laber DA.   +6 more
europepmc   +1 more source

Translation of a physiologically-based pharmacokinetic model for dabigatran etexilate to the design of a safety and efficacy study in post-partum women. [PDF]

Br J Clin Pharmacol
Ogungbenro K, Aucott L, Kamali F, Ayuk P.   +3 more
europepmc   +1 more source

Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]

Pharmacoepidemiol Drug Saf
Ojeda-Fernández L, Agostini G, Zanovello A, Prada P, Fortino I, Augurio C, Baviera M.   +6 more
europepmc   +1 more source

Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial. [PDF]

BMJ Open
McDonald EG, Cheng MP, Davis JS, Goodman AL, Lawler PR, Marsh J, Mertz D, Paul M, Rodriguez-Baño J, Siegal DM, Tong SY, Walls G, Lee TC, SNAP Global Trial Steering Committee.   +13 more
europepmc   +1 more source

Direct oral anticoagulant interference and removal in the factor VIII inhibitor assay. [PDF]

Res Pract Thromb Haemost
Timmerije R, Schols SEM, Meijer D, Barteling W, Stroobants AK, Rijpma SR.   +5 more
europepmc   +1 more source

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]

BMC Med
Liang M, Jin J, Zhao R, Li H, Chen S, Liu L, Xu P, Wang W, Cheng X, Chen X, Tao L, Zhang Q, Yang M, Zeng C, Li L, Zheng Y, Chen H, Guo J, Zhong Z, Bi Y, Cheng B, Zhou Y, Wang H, Zhang Y, Qiu M, Zhang Q, Zhang P, Zhang J, Wang Z, Li Y, Han Y.   +30 more
europepmc   +1 more source

Comparative Renal Outcomes and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation: Insights from Real-World Data. [PDF]

Medicina (Kaunas)
Tongkate K, Chantrarat T, Boonmuang P, Saelim W, Ruenroengbun N, Kongwatcharapong J.   +5 more
europepmc   +1 more source

NOACs effects in the secondary prevention of atrial fibrillation-related ischemic stroke/TIA: a systematic review and meta-analysis. [PDF]

J Neurol
Zhao J, Chen C, Lu L, Wang L, Chen F.
europepmc   +1 more source